Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

Annals of Surgery

Volumn 226, Issue 6, 1997, Pages 688-703

  Majno, Pietro E ^a   Adam, René ^b   Bismuth, Henri ^a   Castaing, Denis ^a   Ariche, Arie ^a   Krissat, Jinane ^b   Perrin, Hubert ^b   Azoulay, Daniel ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; COMORBIDITY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; IODIZED OIL; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031474934     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199712000-00006     Document Type: Article

References (14)

1. Ganne-Carié N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 1996;23:im-1118.
2. Akashi Y, Koreeda C, Enomoto S, et al. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 1991; 14:262-268
3. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148:397-401.
4. Kasugai H, Kojima J, Tatsuta M, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989;97:965-971.
5. Yamashita Y, Takahashi M, Koga Y, et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 1991;67:385-391.
6. Vetter D, Wenger JJ, Bergier JM, et al. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a western comparative study in 60 patients. Hepatology 1991; 13:427-433.
7. Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992;163:387-394.
8. Ikeda K, Kumada H, Saitoshi S, et al. Effect of repeated transcatheter arterial embolization on survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional hazard model. Cancer 1991:15:2150-2154.
9. Madden MV, Krige JEJ, Bailey S, et al. Randomized trial of targeted chemotherapy with lipiodol and 5-epidoorubicin compared with symptomatic treatment for hepatoma. Gut 1993:34:1598-1600.
10. Groupe d'étude et de traitement du carcinome hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995:332:1256-1261.
11. Pelletier G, Roche A, Ink O, et al. A randomized trial in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11:181-184.
12. Harada T, Matsuo K, Inoue T, et al. Is preoperative arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996;224:4-9.
13. Uchida M, Kohno H, Kubota H, et al. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma. World J Surg 1996:20:326-331.
14. Nagasue N, Galizia G, Kohno H. Adverse effect of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 1989:106:81-81.